CASI Pharmaceuticals
Earnings Surprise
Analysts estimated CASI earnings of $-0.41 per share this quarter (Q3). CASI's actual earnings were $-0.67 per share.
CASI EPS surprise of -64.22%Analysts estimated CASI earnings of $-0.48 per share this quarter (Q2). CASI's actual earnings were $-0.86 per share.
CASI EPS surprise of -79.39%Analysts estimated CASI earnings of $-0.62 per share this quarter (Q1). CASI's actual earnings were $-0.69 per share.
CASI EPS surprise of -10.90%Analysts estimated CASI earnings of $-0.63 per share this quarter (Q3). CASI's actual earnings were $-0.55 per share.
CASI EPS surprise of 13.03%Analysts estimated CASI earnings of $-0.64 per share this quarter (Q2). CASI's actual earnings were $-0.55 per share.
CASI EPS surprise of 14.41%Analysts estimated CASI earnings of $-0.05 per share this quarter (Q1). CASI's actual earnings were $-0.71 per share.
CASI EPS surprise of -1292.16%Analysts estimated CASI earnings of $-0.24 per share this quarter (Q4). CASI's actual earnings were $-0.45 per share.
CASI EPS surprise of 83.82%Analysts estimated CASI earnings of $-0.57 per share this quarter (Q3). CASI's actual earnings were $-0.35 per share.
CASI EPS surprise of -38.73%